市場調査レポート
商品コード
1090079

薬事業務アウトソーシングの世界市場:サービス別、企業規模別、カテゴリー別、適応症別、ステージ別、エンドユーザー別、地域別の市場規模と予測(2022年~2028年)

Global Regulatory Affairs Outsourcing Market Size study, by Services, by Company Size, by Category, by Indication, by Stage (Preclinical, Clinical, PMA), by End-use, and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
薬事業務アウトソーシングの世界市場:サービス別、企業規模別、カテゴリー別、適応症別、ステージ別、エンドユーザー別、地域別の市場規模と予測(2022年~2028年)
出版日: 2022年06月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬事業務アウトソーシングの市場規模は、2021年に約57億2,000万米ドルと評価され、2022年~2028年の予測期間中に8.90%以上の健全な成長率で成長すると予想されています。

市場を牽引しているのは、研究開発活動の活発化による臨床試験の申請件数や製品登録件数が増加です。さらに、生物製剤の増加、革新的な技術に対する高い需要、個別化された希少疾病用医薬品・医学のニーズなどが、予測期間中の成長を促進すると予想されます。しかし、2022年~2028年の予測期間においては、様々な医療品目を管理する政府の厳格な規制が市場成長を抑制すると予想されます。

当レポートでは、世界の薬事業務アウトソーシング市場について調査分析し、市場動向、業界分析、COVID-19の影響、セグメント別・地域別の市場分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の薬事業務アウトソーシング市場の定義と範囲

第3章 世界の薬事業務アウトソーシング市場力学

  • 薬事業務アウトソーシング市場の影響分析(2020年~2028年)

第4章 世界の薬事業務アウトソーシング市場の業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前・COVID-19後の市場シナリオ

第6章 世界の薬事業務アウトソーシング市場:サービス別

  • 市場スナップショット
  • 実績・潜在性分析:サービス別
  • 推定と予測:サービス別(2018年~2028年)
  • サブセグメント分析
    • 規制コンサルティング
    • 法定代理人
    • 規制文書の作成と公開
    • 製品登録と臨床試験の申請
    • その他のサービス

第7章 世界の薬事業務アウトソーシング市場:企業規模別

  • 市場スナップショット
  • 実績・潜在性分析:企業規模別
  • 推定と予測:企業規模別(2018年~2028年)
  • サブセグメント分析
    • 小規模
    • 中規模
    • 大規模

第8章 世界の薬事業務アウトソーシング市場:カテゴリー別

  • 市場スナップショット
  • 実績・潜在性分析:カテゴリー別
  • 推定と予測:カテゴリー別(2018年~2028年)
  • サブセグメント分析
    • 医薬品
    • ジェネリック
    • イノベーター
    • 生物製剤
    • バイオテクノロジー
    • ATMP
    • バイオシミラー
    • 医療機器
    • 治療
    • 診断

第9章 世界の薬事業務アウトソーシング市場:適応症別

  • 市場スナップショット
  • 実績・潜在性分析:適応症別
  • 推定と予測:適応症別(2018年~2028年)
  • サブセグメント分析
    • 腫瘍学
    • 神経学
    • 心臓病学
    • 免疫学
    • その他

第10章 世界の薬事業務アウトソーシング市場:段階別

  • 市場スナップショット
  • 実績・潜在性分析:段階別
  • 推定と予測:段階別(2018年~2028年)
  • サブセグメント分析
    • 前臨床
    • 臨床
    • PMA(Post Market Authorization)

第11章 世界の薬事業務アウトソーシング市場:最終用途別

  • 市場スナップショット
  • 実績・潜在性分析:最終用途別
  • 推定と予測:最終用途別(2018年~2028年)
  • サブセグメント分析
    • 医療機器企業
    • 製薬企業
    • バイオテクノロジー企業

第12章 世界の薬事業務アウトソーシング市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第13章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Accell Clinical Research, LLC
    • GenPact Ltd.
    • Criterium, Inc.
    • PRA Health Sciences
    • Promedica International
    • Dr. Regenold GmbH
    • BioMapas
    • Zeincro Group
    • Parexel International Corp.
    • Charles River Laboratories International, Inc.

第14章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Regulatory Affairs Outsourcing Market, report scope
  • TABLE 2. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Services 2018-2028 (USD Billion)
  • TABLE 4. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Company Size 2018-2028 (USD Billion)
  • TABLE 5. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Category 2018-2028 (USD Billion)
  • TABLE 6. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Indication 2018-2028 (USD Billion)
  • TABLE 7. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Stage 2018-2028 (USD Billion)
  • TABLE 8. Global Regulatory Affairs Outsourcing Market estimates & forecasts by End-use 2018-2028 (USD Billion)
  • TABLE 9. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 18. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 19. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. Canada Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. Canada Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. Canada Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. UK Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. UK Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. UK Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. Germany Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. Germany Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. Germany Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. RoE Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. RoE Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. RoE Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. China Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. China Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. China Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. India Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. India Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. India Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. Japan Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. Japan Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. Japan Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. Row Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 56. Row Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 57. Row Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 58. List of secondary sources, used in the study of global Regulatory Affairs Outsourcing Market
  • TABLE 59. List of primary sources, used in the study of global Regulatory Affairs Outsourcing Market
  • TABLE 60. Years considered for the study
  • TABLE 61. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Regulatory Affairs Outsourcing Market, research methodology
  • FIG 2. Global Regulatory Affairs Outsourcing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Regulatory Affairs Outsourcing Market, key trends 2021
  • FIG 5. Global Regulatory Affairs Outsourcing Market, growth prospects 2022-2028
  • FIG 6. Global Regulatory Affairs Outsourcing Market, porters 5 force model
  • FIG 7. Global Regulatory Affairs Outsourcing Market, pest analysis
  • FIG 8. Global Regulatory Affairs Outsourcing Market, value chain analysis
  • FIG 9. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Regulatory Affairs Outsourcing Market, regional snapshot 2018 & 2028
  • FIG 15. North America Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Regulatory Affairs Outsourcing Market, company Market share analysis (2021)
目次

Global Regulatory Affairs Outsourcing Market is valued approximately USD 5.72 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.90 % over the forecast period 2022-2028. Regulatory affairs outsourcing is becoming more common in the healthcare industry. The adoption of regulatory outsourcing models is projected to be aided by an increase in geographical expansion activities by corporations seeking quick approvals in local markets. The regulatory affairs outsourcing market is quickly growing as a result of increased R&D activity, which is increasing the number of clinical trial applications and product registrations. Outsourcing of regulatory affairs duties is being driven by a significant increase in the fixed expenses of in-house resources for regulatory affairs and operations activities such as training, technology, specialist knowledge, and facilities. For example, ProPharma Group bought iSafety Systems, an Indian pharmacovigilance service provider, in August 2021 to boost its pharmacovigilance market position. Similarly, in July 2021, ICON plc purchased PRA Health Sciences, contract research organization that specializes in medication development and regulatory consultation. The goal of this acquisition was to expand ICON plc's service portfolio. The demand for these services is being driven by local legal challenges and frequent changes in the rules of major markets such as the United States, Europe, and Asia.. Amendments to current regulations are likely to make the regulatory process easier for the business, but they will also make it more difficult for healthcare product manufacturers to operate. As a result, regulatory affairs are being outsourced to service providers. This is due to an increase in the number of clinical trial registrations in recent years. ClinicalTrials.gov reports that about 401,716 studies were registered in January 2022, up from around 325,834 by the end of 2019. Furthermore, an increase in the number of biologics, a high demand for innovative technologies, and a need for individualized orphan pharmaceuticals and medicine are all expected to drive segment growth throughout the projection period. However, over the projection period of 2022-2028, rigorous government regulations governing various medical items would stifle market growth.

The key regions considered for the global Regulatory Affairs Outsourcing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The Asia Pacific area had the largest share. Over the forecast period, the area is also expected to have the quickest CAGR. This can be linked to an increase in clinical trials as well as a rise in the number of enterprises attempting to penetrate developing markets such as India and China. Another element projected to drive regional market expansion is the availability of a competent labour in the region at cheaper costs than in the United States.

Major market player included in this report are:

Accell Clinical Research, LLC

GenPact Ltd.

Criterium, Inc.

PRA Health Sciences

Promedica International

Dr. Regenold GmbH

BioMapas

Zeincro Group

Parexel International Corp.

Charles River Laboratories International, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Services

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration & Clinical Trial Applications

Other Services

By Company Size

Small

Medium

Large

By Category

Drugs

Generics

Innovators

Biologics

Biotech

ATMPs

Biosimilars

Medical devices

Therapeutic

Diagnostic

By Indication

Oncology

Neurology

Cardiology

Immunology

Others

By Stage

Preclinical

Clinical

PMA (Post Market Authorization)

By End-use

Medical Device Companies

Pharmaceutical Companies

Biotechnology Companies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Regulatory Affairs Outsourcing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Regulatory Affairs Outsourcing Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Regulatory Affairs Outsourcing Market, by Services, 2020-2028 (USD Billion)
    • 1.2.3. Regulatory Affairs Outsourcing Market, by Company Size, 2020-2028 (USD Billion)
    • 1.2.4. Regulatory Affairs Outsourcing Market, by Category, 2020-2028 (USD Billion)
    • 1.2.5. Regulatory Affairs Outsourcing Market, by Indication, 2020-2028 (USD Billion)
    • 1.2.6. Regulatory Affairs Outsourcing Market, by Stage, 2020-2028 (USD Billion)
    • 1.2.7. Regulatory Affairs Outsourcing Market, by End-use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Regulatory Affairs Outsourcing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Regulatory Affairs Outsourcing Market Dynamics

  • 3.1. Regulatory Affairs Outsourcing Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities
      • 3.1.1.2. Augmenting the volume of clinical trial applications and product registration
    • 3.1.2. Market Challenges
      • 3.1.2.1. Strict government regulations regarding the various medical products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in geographical expansion activities by companies
      • 3.1.3.2. Increase in R&D activities

Chapter 4. Global Regulatory Affairs Outsourcing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Regulatory Affairs Outsourcing Market, by Services

  • 6.1. Market Snapshot
  • 6.2. Global Regulatory Affairs Outsourcing Market by Services, Performance - Potential Analysis
  • 6.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Services 2018-2028 (USD Billion)
  • 6.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 6.4.1. Regulatory Consulting
    • 6.4.2. Legal Representation
    • 6.4.3. Regulatory Writing & Publishing
    • 6.4.4. Product Registration & Clinical Trial Applications
    • 6.4.5. Other Services

Chapter 7. Global Regulatory Affairs Outsourcing Market, by Company Size

  • 7.1. Market Snapshot
  • 7.2. Global Regulatory Affairs Outsourcing Market by Company Size, Performance - Potential Analysis
  • 7.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Company Size 2018-2028 (USD Billion)
  • 7.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 7.4.1. Small
    • 7.4.2. Medium
    • 7.4.3. Large

Chapter 8. Global Regulatory Affairs Outsourcing Market, by Category

  • 8.1. Market Snapshot
  • 8.2. Global Regulatory Affairs Outsourcing Market by Category, Performance - Potential Analysis
  • 8.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Category 2018-2028 (USD Billion)
  • 8.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 8.4.1. Drugs
    • 8.4.2. Generics
    • 8.4.3. Innovators
    • 8.4.4. Biologics
    • 8.4.5. Biotech
    • 8.4.6. ATMPs
    • 8.4.7. Biosimilars
    • 8.4.8. Medical devices
    • 8.4.9. Therapeutic
    • 8.4.10. Diagnostic

Chapter 9. Global Regulatory Affairs Outsourcing Market, by Indication

  • 9.1. Market Snapshot
  • 9.2. Global Regulatory Affairs Outsourcing Market by Indication, Performance - Potential Analysis
  • 9.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)
  • 9.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 9.4.1. Oncology
    • 9.4.2. Neurology
    • 9.4.3. Cardiology
    • 9.4.4. Immunology
    • 9.4.5. Others

Chapter 10. Global Regulatory Affairs Outsourcing Market, by Stage

  • 10.1. Market Snapshot
  • 10.2. Global Regulatory Affairs Outsourcing Market by Stage, Performance - Potential Analysis
  • 10.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Stage 2018-2028 (USD Billion)
  • 10.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 10.4.1. Preclinical
    • 10.4.2. Clinical
    • 10.4.3. PMA (Post Market Authorization)

Chapter 11. Global Regulatory Affairs Outsourcing Market, by End-use

  • 11.1. Market Snapshot
  • 11.2. Global Regulatory Affairs Outsourcing Market by End-use, Performance - Potential Analysis
  • 11.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
  • 11.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 11.4.1. Medical Device Companies
    • 11.4.2. Pharmaceutical Companies
    • 11.4.3. Biotechnology Companies

Chapter 12. Global Regulatory Affairs Outsourcing Market, Regional Analysis

  • 12.1. Regulatory Affairs Outsourcing Market, Regional Market Snapshot
  • 12.2. North America Regulatory Affairs Outsourcing Market
    • 12.2.1. U.S. Regulatory Affairs Outsourcing Market
      • 12.2.1.1. Services breakdown estimates & forecasts, 2018-2028
      • 12.2.1.2. Company Size breakdown estimates & forecasts, 2018-2028
      • 12.2.1.3. Category breakdown estimates & forecasts, 2018-2028
      • 12.2.1.4. Indication breakdown estimates & forecasts, 2018-2028
      • 12.2.1.5. Stage breakdown estimates & forecasts, 2018-2028
      • 12.2.1.6. End-use breakdown estimates & forecasts, 2018-2028
    • 12.2.2. Canada Regulatory Affairs Outsourcing Market
  • 12.3. Europe Regulatory Affairs Outsourcing Market Snapshot
    • 12.3.1. U.K. Regulatory Affairs Outsourcing Market
    • 12.3.2. Germany Regulatory Affairs Outsourcing Market
    • 12.3.3. France Regulatory Affairs Outsourcing Market
    • 12.3.4. Spain Regulatory Affairs Outsourcing Market
    • 12.3.5. Italy Regulatory Affairs Outsourcing Market
    • 12.3.6. Rest of Europe Regulatory Affairs Outsourcing Market
  • 12.4. Asia-Pacific Regulatory Affairs Outsourcing Market Snapshot
    • 12.4.1. China Regulatory Affairs Outsourcing Market
    • 12.4.2. India Regulatory Affairs Outsourcing Market
    • 12.4.3. Japan Regulatory Affairs Outsourcing Market
    • 12.4.4. Australia Regulatory Affairs Outsourcing Market
    • 12.4.5. South Korea Regulatory Affairs Outsourcing Market
    • 12.4.6. Rest of Asia Pacific Regulatory Affairs Outsourcing Market
  • 12.5. Latin America Regulatory Affairs Outsourcing Market Snapshot
    • 12.5.1. Brazil Regulatory Affairs Outsourcing Market
    • 12.5.2. Mexico Regulatory Affairs Outsourcing Market
  • 12.6. Rest of The World Regulatory Affairs Outsourcing Market

Chapter 13. Competitive Intelligence

  • 13.1. Top Market Strategies
  • 13.2. Company Profiles
    • 13.2.1. Accell Clinical Research, LLC
      • 13.2.1.1. Key Information
      • 13.2.1.2. Overview
      • 13.2.1.3. Financial (Subject to Data Availability)
      • 13.2.1.4. Company Size Summary
      • 13.2.1.5. Recent Developments
    • 13.2.2. GenPact Ltd.
    • 13.2.3. Criterium, Inc.
    • 13.2.4. PRA Health Sciences
    • 13.2.5. Promedica International
    • 13.2.6. Dr. Regenold GmbH
    • 13.2.7. BioMapas
    • 13.2.8. Zeincro Group
    • 13.2.9. Parexel International Corp.
    • 13.2.10. Charles River Laboratories International, Inc.

Chapter 14. Research Process

  • 14.1. Research Process
    • 14.1.1. Data Mining
    • 14.1.2. Analysis
    • 14.1.3. Market Estimation
    • 14.1.4. Validation
    • 14.1.5. Publishing
  • 14.2. Research Attributes
  • 14.3. Research Assumption